Dissemin is shutting down on January 1st, 2025

Published in

BioMed Central, BMC Health Services Research, 1(15), 2015

DOI: 10.1186/s12913-015-1100-0

Links

Tools

Export citation

Search in Google Scholar

Cost of stroke: a controlled national study evaluating societal effects on patients and their partners

Journal article published in 2015 by Poul Jennum, Helle K. Iversen, Rikke Ibsen, Jakob Kjellberg ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Abstract Background To estimate the direct and indirect costs of stroke in patients and their partners. Description Direct and indirect costs were calculated using records from the Danish National Patient Registry from 93,047 ischemic, 26,012 hemorrhagic and 128,824 unspecified stroke patients and compared with 364,433, 103,741 and 500,490 matched controls, respectively. Results Independent of age and gender, stroke patients had significantly higher rates of mortality, health-related contacts, medication use and lower employment, lower income and higher social-transfer payments than controls. The attributable cost of direct net health care costs after the stroke (general practitioner services, hospital services, and medication) and indirect costs (loss of labor market income) were €10,720, €8,205 and €7,377 for patients, and €989, €1,544 and €1.645 for their partners, over and above that of controls for hemorrhagic, ischemic and unspecified stroke, respectively. The negative social- and health-related status could be identified up to eleven years before the first diagnosis. Conclusion Stroke has significant mortality, morbidity and socioeconomic consequences for patients, their partners and society.